Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$123.01M
Total Bought:
$50.43M
Total Sold:
$28.57M
Net Transaction:
+$21.86M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Verastem, Inc.(VSTM)1,360,3862,670,032+1,309,646$5.65M$23.58M19.17%+$17.93M
Adma Biologics Inc750,000739,000-11,000$13.66M$10.83M8.81%-$2.82M
Evolus, Inc.(EOLS)916,5001,536,391+619,891$8.44M$9.43M7.67%+$992.5K
Zevra Therapeutics, Inc.(ZVRA)775,620810,000+34,380$6.83M$7.70M6.26%+$869.9K
Nektar Therapeutics(NKTR)50,20085,000+34,800$1.30M$4.84M3.93%+$3.54M
Day One Biopharmaceuticals I
COM
450,000647,382+197,382$2.92M$4.56M3.71%+$1.64M
Xoma Royalty Corporation152,143115,459-36,684$3.83M$4.45M3.62%+$615.8K
Acadia Pharmaceuticals Inc225,000174,544-50,456$4.85M$3.72M3.03%-$1.13M
Enanta Pharmaceuticals, Inc.(ENTA)604,066305,000-299,066$4.57M$3.65M2.97%-$915.9K
X4 Pharmaceuticals, Inc.(XFOR)01,056,338+1,056,338$0$3.61M2.94%+$3.61M
OmniAb, Inc.(OABI)02,142,857+2,142,857$0$3.43M2.79%+$3.43M
Surrozen, Inc.(SRZN)306,029250,146-55,883$2.74M$3.22M2.62%+$487.2K
TELA Bio, Inc.(TELA)2,083,7622,155,519+71,757$4.04M$3.21M2.61%-$830.8K
Indivior Plc350,000100,000-250,000$5.16M$2.41M1.96%-$2.75M
Abeona Therapeutics Inc.(ABEO)45,000450,970+405,970$255.6K$2.38M1.94%+$2.13M
Geron Corporation(GERN)1,000,0001,600,000+600,000$1.41M$2.19M1.78%+$782.0K
PMV Pharmaceuticals, Inc.(PMVP)845,9681,370,139+524,171$896.7K$1.92M1.56%+$1.02M
Edesa Biotech, Inc.(EDSA)0687,500+687,500$0$1.70M1.38%+$1.70M
Aytu Biopharma Inc812,676891,855+79,179$1.77M$1.68M1.36%-$94.9K
Soleno Therapeutics Inc024,000+24,000$0$1.62M1.32%+$1.62M
Kezar Life Sciences Inc
COM NEW
169,859383,182+213,323$778.0K$1.49M1.21%+$716.5K
Alumis Inc349,615300,000-49,615$1.05M$1.20M0.97%+$148.2K
Inhibikase Therapeutics, Inc.(IKT)733,793735,019+1,226$1.43M$1.19M0.97%-$240.2K
BioAge Labs, Inc.(BIOA)151,085188,571+37,486$624.0K$1.11M0.90%+$484.8K
Ardelyx Inc555,000200,000-355,000$2.18M$1.10M0.90%-$1.07M
Pulmonx Corporation(LUNG)145,900670,000+524,100$377.9K$1.09M0.88%+$707.5K
Dynavax Technologies Corp30,000108,094+78,094$297.6K$1.07M0.87%+$775.8K
Heron Therapeutics, Inc.(HRTX)657,380850,100+192,720$1.36M$1.07M0.87%-$289.7K
Vanda Pharmaceuticals Inc.(VNDA)250,000195,000-55,000$1.18M$973.0K0.79%-$206.9K
Vir Biotechnology, Inc.(VIR)130,000160,000+30,000$655.2K$913.6K0.74%+$258.4K
MannKind Corporation(MNKD)0157,569+157,569$0$846.1K0.69%+$846.1K
MaxCyte, Inc.(MXCT)0459,018+459,018$0$725.2K0.59%+$725.2K
An2 Therapeutics Inc544,494563,913+19,419$577.2K$716.2K0.58%+$139.0K
Zentalis Pharmaceuticals, Inc.(ZNTL)109,010453,800+344,790$126.5K$685.2K0.56%+$558.8K
AngioDynamics, Inc.(ANGO)77,14160,000-17,141$765.2K$670.2K0.54%-$95.0K
Grace Therapeutics, Inc.(GRCE)292,500211,010-81,490$868.7K$628.2K0.51%-$240.5K
Ultragenyx Pharmaceutical Inc.(RARE)020,000+20,000$0$601.6K0.49%+$601.6K
Syndax Pharmaceuticals, Inc.(SNDX)92,90037,200-55,700$870.0K$572.3K0.47%-$297.7K
Aquestive Therapeutics Inc0100,600+100,600$0$562.4K0.46%+$562.4K
Gossamer Bio, Inc.(GOSS)0204,770+204,770$0$538.5K0.44%+$538.5K
Boundless Bio, Inc.(BOLD)106,175413,453+307,278$107.2K$508.5K0.41%+$401.3K
Health Catalyst, Inc.(HCAT)100,000155,551+55,551$377.0K$443.3K0.36%+$66.3K
Establishment Labs Holdings Inc.(ESTA)7,00010,585+3,585$299.0K$433.9K0.35%+$134.9K
Pliant Therapeutics, Inc.(PLRX)0289,237+289,237$0$428.1K0.35%+$428.1K
CytomX Therapeutics, Inc.(CTMX)0125,000+125,000$0$398.8K0.32%+$398.8K
Kiora Pharmaceuticals, Inc.(KPRX)178,000140,598-37,402$512.6K$390.9K0.32%-$121.8K
Rezolute, Inc.(RZLT)219,00040,000-179,000$976.7K$376.0K0.31%-$600.7K
Aclaris Therapeutics, Inc.(ACRS)491,300192,900-298,400$697.6K$366.5K0.30%-$331.1K
In8bio Inc82,430159,421+76,991$172.3K$345.9K0.28%+$173.7K
Solana CompanyCL A(HSDT)020,000+20,000$0$297.8K0.24%+$297.8K
Codexis, Inc.(CDXS)088,264+88,264$0$215.4K0.18%+$215.4K
Savara Inc.(SVRA)85,00060,000-25,000$193.8K$214.2K0.17%+$20.4K
ABIVAX Société AnonymeADS(ABVX)02,500+2,500$0$212.3K0.17%+$212.3K
Processa Pharmaceuticals Inc01,030,200+1,030,200$0$197.7K0.16%+$197.7K
Larimar Therapeutics, Inc.(LRMR)025,000+25,000$0$80.8K0.07%+$80.8K
Chemomab Therapeutics Ltd.ADS(CMMB)030,000+30,000$0$78.9K0.06%+$78.9K
Whitehawk Therapeutics, Inc.(WHWK)035,253+35,253$0$67.0K0.05%+$67.0K
Jasper Therapeutics, Inc.(JSPR)020,200+20,200$0$48.1K0.04%+$48.1K
Achieve Life Sciences Inc333,3330-333,333$753.3K$0—-$753.3K
ANI Pharmaceuticals, Inc.(ANIP)38,5970-38,597$2.52M$0—-$2.52M
Anika Therapeutics Inc190,5900-190,590$2.02M$0—-$2.02M
CalciMedica, Inc.(CALC)85,0000-85,000$136.0K$0—-$136.0K
Climb Bio, Inc.(CLYM)116,1470-116,147$144.0K$0—-$144.0K
Coherus Oncology, Inc.(CHRS)62,7000-62,700$45.9K$0—-$45.9K
Collegium Pharmaceutical, Inc.(COLL)41,5000-41,500$1.23M$0—-$1.23M
Hillevax Inc226,0090-226,009$449.8K$0—-$449.8K
Iteos Therapeutics Inc310,0330-310,033$3.09M$0—-$3.09M
Kalvista Pharmaceuticals Inc100,0000-100,000$1.13M$0—-$1.13M
Kura Oncology, Inc.(KURA)25,0000-25,000$144.3K$0—-$144.3K
Liquidia Corporation(LQDA)50,0000-50,000$623.0K$0—-$623.0K
Monte Rosa Therapeutics, Inc.(GLUE)30,0000-30,000$135.3K$0—-$135.3K
Myomo, Inc.(MYO)457,4190-457,419$988.0K$0—-$988.0K
Nuvation Bio Inc.CL A(NUVB)85,3000-85,300$166.3K$0—-$166.3K
Spero Therapeutics, Inc.(SPRO)156,8880-156,888$455.0K$0—-$455.0K
Theratechnologies Inc189,0510-189,051$446.2K$0—-$446.2K
Xeris Biopharma Holdings Inc205,1000-205,100$957.8K$0—-$957.8K
Y-Mabs Therapeutics Inc285,3000-285,300$1.29M$0—-$1.29M
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q3 2025 | TickerTrail